Is curing your patients a sustainable business model?

The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided.

Are cures profitable?

University of Calgary economist Aidan Hollis said cures are still good business. “If you can come up with a cure that you can charge people a lot for, then in a competitive market that’s going to be very effective and you’re going to make a lot of money for it.”

Did Goldman Sachs ask if curing patients was a sustainable business model?

Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model? CNBC. “Goldman Sachs analysts attempted to address a touchy subject for biotech companies, especially those involved in the pioneering “gene therapy” treatment: cures could be bad for business in the long run.”

What is Goldman Sachs do?

The Goldman Sachs Group, Inc. is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and individuals.

Is Goldman Sachs an LLC?

Goldman Sachs & Co. LLC operates as an investment management company. The Company offers investment banking, securities, asset management, capital market, valuation, bonds, funds, financial analysis, investment strategies, and advisory services.

What is the business of JP Morgan?

Our company is a leading global financial services firm with assets of $2.6 trillion and operations worldwide. Our rich history spans over 200 years. We are a leader in investment banking, financial services for consumers and small business, commercial banking, financial transactions processing and asset management.

What was David Solomon’s degree?

Hamilton College
Edgemont Jr./Sr. High School
David M. Solomon/Education

Is Solomon divorced?

David Michael Solomon (born c. 1962) is an American investment banker, and the chief executive officer (CEO) of Goldman Sachs, a position he has held since October 2018….David M. Solomon.

David Solomon
Spouse(s)	Mary Solomon ​ ​ ( m. 1989; div. 2018)​
Musical career
Genres	EDM dance pop electro house synth-pop

What is CIB J.P. Morgan?

Corporate & Investment Banking Research & Analytics Program Enhance your skillset and develop business acumen by working on creative solutions across businesses and expand your network to include the best talent in the industry.

Is curing a disease a sustainable business model?

Goldman may have a point that curing a single disease may not be a sustainable business model, but looking at the business as a single treatment for a single disease doesn’t make sense — it’s like saying construction isn’t sustainable because once you’ve built a building that person doesn’t ever need another building.

Is the Genome Revolution a sustainable business model?

The investment banks’ report, titled “The Genome Revolution,” asks clients the touchy question: “Is curing patients a sustainable business model?” The answer may be “no,” according to follow-up information provided. Analyst Salveen Richter and colleagues laid it out:

Is a cure for cancer a sustainable risk to franchisees?

Where an incident pool remains stable (eg, in cancer) the potential for a cure poses less risk to the sustainability of a franchise.” The analyst didn’t immediately respond to a request for comment.

Should Genome Medicine developers care about sustained cash flow?

“While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow.” Richter cited Gilead Sciences’ treatments for hepatitis C, which achieved cure rates of more than 90 percent.